Comparison of venous and arterial blood sampling for the assessment of platelet aggregation with whole blood impedance aggregometry

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 71, Issue 8, 2011, Pages 637-640

  Kafian, Sam ^a   Mobarrez, Fariborz ^a   Kalani, Majid ^a   Wallén, Hkan ^a   Samad, Bassem A ^a  

^a DANDERYD HOSPITAL   (Sweden)

Author keywords

aspirin; Clopidogrel; coronary artery disease; impedance aggregometry; percutaneous coronary intervention; venous blood and arterial blood

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CLOPIDOGREL;

ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CEPHALIC VEIN; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORONARY ARTERY DISEASE; DRUG RESPONSE; FEMALE; HEMODYNAMIC MONITORING; HUMAN; IMPEDANCE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; VENOUS BLOOD;

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; AREA UNDER CURVE; ARTERIES; ASPIRIN; BLOOD PLATELETS; CORONARY ARTERY DISEASE; ELECTRIC IMPEDANCE; FEMALE; HUMANS; MALE; PHLEBOTOMY; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; RESEARCH DESIGN; SPECIMEN HANDLING; TICLOPIDINE; VEINS;

EID: 81255143218     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2011.604731     Document Type: Article

References (11)

1. Collet JP, Van Werkum JW. Individualised antiplatelet therapy - Is there a role for platelet function testing in routine clinical practice? Intervent Cardiol 2010;5:96-103.
2. Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schöm ig A, Kastrati A, von Beckerath N. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J. Am. Coll. Cardiol. 2009;53:849-56.
3. Paniccia R, Antonucci E, Maggini N, Miranda M, Gori AM, Marcucci R, Giusti B, Balzi D, Prisco D, Abbate R. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients. Thromb Haemost 2010;104: 287-92.
4. Breddin HK. Can platelet aggregometry be standardized? Platelets 2005;16:151-8 .
5. Wallé n NH, Ladjevardi M, Albert J, Bröi jers é n A. Infl uence of different anticoagulants on platelet aggregation in whole blood: A comparison between citrate, low molecular mass heparin and hirudin. Thromb Res 1997;87:151-7.
6. Tót h O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: A new device to measure platelet aggregation in whole blood. Thromb Haemost 2006; 96:781-8.
7. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
8. Sibbing D, Gebhard D, Koch W, Braun S, Stegherr J, M orath T, von Beckerath N, Mehilli J, Schömig A, Schuster T, Kastrati A. Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window. J. Am. Coll. Cardiol. 2010;56:317-8.
9. Mortensen SB, Larsen SB, Grove EL, Kristensen SD, Hvas AM. Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus. Thromb Res 2010;126:318-22.
10. Mundal HH, Nordby G, Lande K, Giesdal K, Kjeldsen SE, Os I. Effect of cold pressor test and awareness of hypertension on platelet function in normotensive and hypertensive women. Scand. J. Clin. Lab. Invest. 1993;53:585-91.
11. Yang Z, Stulz P, Segesser L, Bauer E, Turina M, Luscher TF. Different interactions of platelets with arterial and venous bypass grafts. Lancet 1991;337:939-43.